No products in the cart.
Rabbit Polyclonal Phospho-GSK3beta (S9) antibody (STJ90445)
Supplier: St John’s Laboratory Ltd.
Recommended applications: WB, IHC, ELISA
Recommended dilution: WB 1:500-1:2000; IHC 1:100-1:300; ELISA 1:10000;
Recommended protocols: check protocols
Click or hover above images to see image description for GSK3beta (phospho Ser9) Polyclonal Antibody.
Check alternative names for the antibodyExpand
GSK3B antibody,|Glycogen Synthase Kinase 3 Beta antibody|Glycogen synthase kinase-3 beta antibody|GSK 3 beta antibody|GSK-3 beta antibody|GSK3B antibody|GSK3B_HUMAN antibody|GSK3beta isoform antibody|Serine/threonine-protein kinase GSK3B antibody|Anti-GSK3 beta antibody [Y174] (ab32391)
SCBT cat No: sc-7291|sc-56913|sc-81462|sc-53931|sc-71186|sc-71188|sc-377213|sc-9166|sc-8257|sc-164567|sc-164569|sc-365863|sc-28966|sc-166882|sc-100546|sc-398714|
GSK3beta (phospho Ser9) Polyclonal Antibody
|Catalogue No.|| |
Human, Mouse, Rat
Phospho-GSK3beta (S9) Polyclonal Antibody detects endogenous levels of GSK3beta protein only when phosphorylated at S9.
Synthesized phospho-peptide derived from GSK3beta (phospho Ser9) at AA range 1-80
WB, IHC, ELISA
|Recommended dilution|| |
WB 1:500-1:2000; IHC 1:100-1:300; ELISA 1:10000;
|Molecular weight|| |
GSK3beta (phospho Ser9) Antibody was tube-contained. Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
GSK3beta (phospho Ser9) Antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-20 Celsius degree. Avoid repeated freeze/thaw cycles.
|Alternative antibody names|| |
Glycogen synthase kinase-3 beta antibody, GSK-3 beta antibody, Serine/threonine-protein kinase GSK3B antibody,
|Protein names|| |
Glycogen synthase kinase-3 beta , GSK-3 beta , Serine/threonine-protein kinase GSK3B ,
|Protein function|| |
Constitutively active protein kinase that acts as a negative regulator in the hormonal control of glucose homeostasis, Wnt signaling and regulation of transcription factors and microtubules, by phosphorylating and inactivating glycogen synthase (GYS1 or GYS2), EIF2B, CTNNB1/beta-catenin, APC, AXIN1, DPYSL2/CRMP2, JUN, NFATC1/NFATC, MAPT/TAU and MACF1. Requires primed phosphorylation of the majority of its substrates. In skeletal muscle, contributes to insulin regulation of glycogen synthesis by phosphorylating and inhibiting GYS1 activity and hence glycogen synthesis. May also mediate the development of insulin resistance by regulating activation of transcription factors. Regulates protein synthesis by controlling the activity of initiation factor 2B (EIF2BE/EIF2B5) in the same manner as glycogen synthase. In Wnt signaling, GSK3B forms a multimeric complex with APC, AXIN1 and CTNNB1/beta-catenin and phosphorylates the N-terminus of CTNNB1 leading to its degradation mediated by ubiquitin/proteasomes. Phosphorylates JUN at sites proximal to its DNA-binding domain, thereby reducing its affinity for DNA. Phosphorylates NFATC1/NFATC on conserved serine residues promoting NFATC1/NFATC nuclear export, shutting off NFATC1/NFATC gene regulation, and thereby opposing the action of calcineurin. Phosphorylates MAPT/TAU on ‘Thr-548’, decreasing significantly MAPT/TAU ability to bind and stabilize microtubules. MAPT/TAU is the principal component of neurofibrillary tangles in Alzheimer disease. Plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex. Phosphorylates MACF1, inhibiting its binding to microtubules which is critical for its role in bulge stem cell migration and skin wound repair. Probably regulates NF-kappa-B (NFKB1) at the transcriptional level and is required for the NF-kappa-B-mediated anti-apoptotic response to TNF-alpha (TNF/TNFA). Negatively regulates replication in pancreatic beta-cells, resulting in apoptosis, loss of beta-cells and diabetes. Through phosphorylation of the anti-apoptotic protein MCL1, may control cell apoptosis in response to growth factors deprivation. Phosphorylates MUC1 in breast cancer cells, decreasing the interaction of MUC1 with CTNNB1/beta-catenin. Is necessary for the establishment of neuronal polarity and axon outgrowth. Phosphorylates MARK2, leading to inhibit its activity. Phosphorylates SIK1 at ‘Thr-182’, leading to sustain its activity. Phosphorylates ZC3HAV1 which enhances its antiviral activity. Phosphorylates SNAI1, leading to its BTRC-triggered ubiquitination and proteasomal degradation. Phosphorylates SFPQ at ‘Thr-687’ upon T-cell activation. Phosphorylates NR1D1 st ‘Ser-55’ and ‘Ser-59’ and stabilizes it by protecting it from proteasomal degradation. Regulates the circadian clock via phosphorylation of the major clock components including ARNTL/BMAL1, CLOCK and PER2. Phosphorylates CLOCK AT ‘Ser-427’ and targets it for proteasomal degradation. Phosphorylates ARNTL/BMAL1 at ‘Ser-17’ and ‘Ser-21’ and primes it for ubiquitination and proteasomal degradation. Phosphorylates OGT at ‘Ser-3’ or ‘Ser-4’ which positively regulates its activity. Phosphorylates MYCN in neuroblastoma cells which may promote its degradation . / ATP + [tau protein] = ADP + [tau protein] phosphate. / ATP + a protein = ADP + a phosphoprotein. / Activated by phosphorylation at Tyr-216. In response to insulin, inhibited by phosphorylation at Ser-9 by PKB/AKT1 and RPS6KA3; phosphorylation at this site causes a conformational change, preventing access of substrates to the active site. Inhibited by lithium.
|Protein tissue specificity|| |
Expressed in testis, thymus, prostate and ovary and weakly expressed in lung, brain and kidney. Colocalizes with EIF2AK2/PKR and TAU in the Alzheimer disease (AD) brain.
|Protein sequence and domain|| |
Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. GSK-3 subfamily. / Contains 1 protein kinase domain.
|Protein post-translational modifications|| |
Phosphorylated by AKT1 and ILK1. Upon insulin-mediated signaling, the activated PKB/AKT1 protein kinase phosphorylates and desactivates GSK3B, resulting in the dephosphorylation and activation of GYS1. Activated by phosphorylation at Tyr-216. / Mono-ADP-ribosylation by PARP10 negatively regulates kinase activity.
|Protein cellular localization|| |
Cytoplasm / Nucleus / Cell membrane
AntibodyPlus can customize GSK3beta (phospho Ser9) Antibody according to your requirement, including bulk product size,etc. Please contact firstname.lastname@example.org. AntibodyPlus provide antibody trial sample for your own antibody validation and collects antibody reviews.
St John’s Laboratory Ltd.
|Product type|| |
There are no reviews for this product yet.
By submitting a review, get following benefits:
1. Receive $50 ABcoins as credit for each review.
2. First trial sample order will be fully refunded as credit.
3. Have a chance to win a $50 amazon gift card!
There is no extra validation for this product yet.
Check other extra validated antibodies below: